177Lu-DOTA-8-aminooctanoylbombesin (7-14)-amide
radiopharmaceutical that targets GRP receptors on prostate cancer cells; structure in first source
Also Known As:
177Lu-DOTA-8-Aoc-BBN(7-14)NH2
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results